研究单位:[1]Grand Medical Pty Ltd.[2]Wuhan Jinyintan Hospital Wuhan, Hubei, China[3]Wuhan Union Hospital Wuhan, Hubei, China[4]Xiangya Hospital Central South University Changsha, Hunan, China[5]Zhongda Hospital Southeast University Nanjing, Jiangsu, China[6]The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China河北医科大学第四医院
研究目的:
This study is a Randomized, Double-blinded, Placebo-controlled Phase Ib Study to Evaluate the Safety, Tolerability and Pharmacokinetics of STC314 Injection Administered as Continuous Intravenous Infusion in Chinese Patients with ARDS (Acute Respiratory Distress Syndrome).